Laboratory Developed Testing Market
Laboratory-Developed Testing Market Forecasts to 2030 - Global Analysis By Product (Mass Spectrometry, Microarrays and Next-Generation Sequencing (NGS)), Test Type (Microbiology, Immunology and Molecular Diagnostics), Application, End User and By Geography
According to Stratistics MRC, the Global Laboratory-Developed Testing Market is accounted for $5.86 billion in 2024 and is expected to reach $10.16 billion by 2030 growing at a CAGR of 9.6% during the forecast period. Laboratory-developed testing (LDT) refers to diagnostic tests created, validated, and performed within a single laboratory, often in clinical or research settings. Unlike commercially available tests, LDTs are typically designed to meet the specific needs of a particular laboratory or patient population. They can range from simple assays to complex molecular tests, providing valuable insights into diseases, genetic predispositions, and treatment options. LDTs play a crucial role in advancing personalized medicine and filling gaps in diagnostic capabilities.
According to the World Health Organization, cancer is the leading or second-leading cause of death for those over the age of 70 in 112 of 183 nations, and third or fourth in the other 23 countries.
Market Dynamics:
Driver:
Increasing product offerings related to genetic health risks
As genetic testing becomes more prevalent, there's a growing demand for comprehensive insights into health risks. This driver fuels the expansion of product offerings within the Laboratory-Developed Testing (LDT) market. Companies are broadening their portfolios to include tests that assess a wider range of genetic health risks, catering to diverse consumer needs. These offerings may encompass tests for predispositions to various diseases, pharmacogenomics, and ancestry tracing, among others. By diversifying their products, LDT providers aim to meet the evolving demands of healthcare professionals and consumers while also capitalizing on the increasing interest in personalized medicine and preventive healthcare strategies.
Restraint:
Stringent regulations
Stringent regulations pose significant restraints in the Laboratory Developed Testing (LDT) market, impacting innovation and market entry. These regulations, often enforced by regulatory bodies like the FDA, require rigorous validation and compliance standards for LDTs, increasing the time and cost of development. Companies face hurdles in navigating complex regulatory pathways, limiting their ability to introduce new tests swiftly. Moreover, the evolving nature of regulations necessitates continuous adaptation, further adding to compliance challenges.
Opportunity:
Continuous research on personalized medicines
Continuous research on personalized medicines presents a significant opportunity within the Laboratory Developed Testing (LDT) market. As advancements in genomics and molecular biology accelerate, tailored therapies become increasingly viable. This trend drives the demand for precise diagnostic tools, prompting laboratories to innovate LDTs for individualized treatment strategies. With ongoing research, LDTs can enhance their capabilities to analyze genetic variations and biomarkers, aiding in the customization of medication regimens. This evolution aligns with the shift towards precision medicine, offering a promising avenue for growth and innovation in the LDT sector.
Threat:
Operational barriers faced in conducting diagnostic tests
Operational barriers often arise when conducting diagnostic tests. These hurdles may include regulatory compliance complexities, limited resources for validation and quality control, and challenges in standardizing procedures across different laboratories. Additionally, ensuring consistent supply chain management for reagents and equipment can be problematic. Interoperability issues with existing healthcare systems and data management platforms further complicate the operational landscape.
Covid-19 Impact:
The COVID-19 pandemic has significantly impacted the laboratory-developed testing (LDT) market. With the urgent need for accurate diagnostic testing, there has been a surge in demand for LDTs, particularly for COVID-19 testing kits. This heightened demand has led to increased investment in LDT research and development, as well as regulatory scrutiny to ensure test accuracy and reliability. Furthermore, the pandemic has spurred innovation in LDT technologies, driving the development of faster, more sensitive, and more scalable testing solutions. However, supply chain disruptions and regulatory challenges have also posed obstacles to market growth.
The critical care segment is expected to be the largest during the forecast period
The Critical Care segment within the Laboratory Developed Testing (LDT) market is experiencing notable growth due to several factors. Advancements in medical technology have enabled the development of more sophisticated tests that can rapidly assess critical health indicators in acutely ill patients, driving demand. The rising prevalence of chronic diseases necessitates frequent monitoring of patients in critical care settings, fueling the need for specialized tests. Additionally, the COVID-19 pandemic has underscored the importance of rapid and accurate diagnostics, further boosting the adoption of LDTs in critical care. The customization and flexibility offered by LDTs allow healthcare providers to tailor tests to specific patient needs, enhancing clinical decision-making.
The Genetics segment is expected to have the highest CAGR during the forecast period
In the Laboratory Developed Testing (LDT) market, the genetics segment is experiencing notable growth. Advances in genomic research have unveiled new insights into disease mechanisms and personalized medicine, driving demand for genetic testing. Moreover, the declining cost of genetic sequencing technologies has made such tests more accessible to healthcare providers and patients. Additionally, the increasing prevalence of genetic disorders and the growing awareness of the importance of early detection and prevention are fuelling the adoption of genetic testing services. These tests offer valuable information for disease risk assessment, diagnosis, treatment selection, and monitoring, making them integral to modern healthcare practices.
Region with largest share:
In recent years, Europe has experienced significant growth in the Laboratory-Developed Testing (LDT) market. This growth can be attributed to several factors, including increasing demand for personalized medicine and diagnostics, advancements in technology enabling more sophisticated testing methods, and a rising emphasis on healthcare quality and efficiency. Additionally, Europe's supportive regulatory environment and robust healthcare infrastructure have fostered innovation and investment in LDT. As a result, the region has witnessed a proliferation of laboratories offering specialized testing services, catering to diverse clinical needs.
Region with highest CAGR:
The Laboratory-Developed Testing (LDT) market in North America has witnessed substantial growth driven by several factors. Increased demand for personalized medicine and precision diagnostics has propelled the expansion of LDT services. Additionally, advancements in technology, such as next-generation sequencing and molecular diagnostics, have widened the scope of LDT offerings. Regulatory flexibility in the region has also fostered innovation and accelerated the adoption of LDTs. Moreover, the COVID-19 pandemic has highlighted the importance of diagnostic testing, further boosting the market.
Key players in the market
Some of the key players in Laboratory-Developed Testing market include Abbott Laboratories, Adaptive Biotechnologies, Bio-Rad Laboratories, Inc., Bruker Corporation, Epic Sciences, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Genoptix, Inc., Guardant Health, Illumina, Inc., OPKO Health Inc., Qiagen, Quidel Corporation, Rosetta Genomics Ltd., Siemens Healthcare Private Limited, Sonic Healthcare Ltd. and Thermo Fisher Scientific Inc.
Key Developments:
In June 2024, Bruker Corporation launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells, subcellular organelles, as well as increased sample loading flexibility. Together with new Spectronaut 19 software and the novel PreOmics ENRICHplus kit, Bruker is setting new 4D-Proteomics standards from highest sensitivity to large-scale, deep plasma proteomics.
In March 2024, Global healthcare leader Abbott has announced the launch of its innovative automation solutions, GLP systems Track, to support laboratories’ high-volume needs. With this launch, Abbott aims to strike a balance between quality of care and efficient use of resources. Across different care settings, depending on laboratory size and patient pool, this automation solution can handle bulk test tubes per day.
Products Covered:
• Mass Spectrometry
• Microarrays
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
Test Types Covered:
• Microbiology
• Immunology
• Critical Care
• Clinical Biochemistry
• Haematology
• Molecular Diagnostics
Applications Covered:
• Research and Development (R&D)
• Oncology
• Neurology
• Infectious Diseases
• Genetics
• Autoimmune Disorders
• Commercial Service
End Users Covered:
• Specialty Diagnostics Centers
• Academic Institutes
• Hospital Laboratories
• Clinical Research Organizations
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Laboratory-Developed Testing Market, By Product
5.1 Introduction
5.2 Mass Spectrometry
5.3 Microarrays
5.4 Polymerase Chain Reaction (PCR)
5.5 Next-Generation Sequencing (NGS)
6 Global Laboratory-Developed Testing Market, By Test Type
6.1 Introduction
6.2 Microbiology
6.3 Immunology
6.4 Critical Care
6.5 Clinical Biochemistry
6.6 Haematology
6.6.1 Blood Count Testing
6.6.2 Coagulation and Hemostasis
6.6.3 Hemoglobin Testing
6.7 Molecular Diagnostics
7 Global Laboratory-Developed Testing Market, By Application
7.1 Introduction
7.2 Research and Development (R&D)
7.3 Oncology
7.4 Neurology
7.5 Infectious Diseases
7.6 Genetics
7.7 Autoimmune Disorders
7.8 Commercial Service
8 Global Laboratory-Developed Testing Market, By End User
8.1 Introduction
8.2 Specialty Diagnostics Centers
8.3 Academic Institutes
8.4 Hospital Laboratories
8.5 Clinical Research Organizations
8.6 Other End Users
9 Global Laboratory-Developed Testing Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Abbott Laboratories
11.2 Adaptive Biotechnologies
11.3 Bio-Rad Laboratories, Inc.
11.4 Bruker Corporation
11.5 Epic Sciences, Inc.
11.6 Eurofins Scientific
11.7 F. Hoffmann-La Roche Ltd
11.8 Genoptix, Inc.
11.9 Guardant Health
11.10 Illumina, Inc.
11.11 OPKO Health Inc.
11.12 Qiagen
11.13 Quidel Corporation
11.14 Rosetta Genomics Ltd.
11.15 Siemens Healthcare Private Limited
11.16 Sonic Healthcare Ltd.
11.17 Thermo Fisher Scientific Inc.
List of Tables
1 Global Laboratory-Developed Testing Market Outlook, By Region (2022-2030) ($MN)
2 Global Laboratory-Developed Testing Market Outlook, By Product (2022-2030) ($MN)
3 Global Laboratory-Developed Testing Market Outlook, By Mass Spectrometry (2022-2030) ($MN)
4 Global Laboratory-Developed Testing Market Outlook, By Microarrays (2022-2030) ($MN)
5 Global Laboratory-Developed Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2022-2030) ($MN)
6 Global Laboratory-Developed Testing Market Outlook, By Next-Generation Sequencing (NGS) (2022-2030) ($MN)
7 Global Laboratory-Developed Testing Market Outlook, By Test Type (2022-2030) ($MN)
8 Global Laboratory-Developed Testing Market Outlook, By Microbiology (2022-2030) ($MN)
9 Global Laboratory-Developed Testing Market Outlook, By Immunology (2022-2030) ($MN)
10 Global Laboratory-Developed Testing Market Outlook, By Critical Care (2022-2030) ($MN)
11 Global Laboratory-Developed Testing Market Outlook, By Clinical Biochemistry (2022-2030) ($MN)
12 Global Laboratory-Developed Testing Market Outlook, By Haematology (2022-2030) ($MN)
13 Global Laboratory-Developed Testing Market Outlook, By Blood Count Testing (2022-2030) ($MN)
14 Global Laboratory-Developed Testing Market Outlook, By Coagulation and Hemostasis (2022-2030) ($MN)
15 Global Laboratory-Developed Testing Market Outlook, By Hemoglobin Testing (2022-2030) ($MN)
16 Global Laboratory-Developed Testing Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
17 Global Laboratory-Developed Testing Market Outlook, By Application (2022-2030) ($MN)
18 Global Laboratory-Developed Testing Market Outlook, By Research and Development (R&D) (2022-2030) ($MN)
19 Global Laboratory-Developed Testing Market Outlook, By Oncology (2022-2030) ($MN)
20 Global Laboratory-Developed Testing Market Outlook, By Neurology (2022-2030) ($MN)
21 Global Laboratory-Developed Testing Market Outlook, By Infectious Diseases (2022-2030) ($MN)
22 Global Laboratory-Developed Testing Market Outlook, By Genetics (2022-2030) ($MN)
23 Global Laboratory-Developed Testing Market Outlook, By Autoimmune Disorders (2022-2030) ($MN)
24 Global Laboratory-Developed Testing Market Outlook, By Commercial Service (2022-2030) ($MN)
25 Global Laboratory-Developed Testing Market Outlook, By End User (2022-2030) ($MN)
26 Global Laboratory-Developed Testing Market Outlook, By Specialty Diagnostics Centers (2022-2030) ($MN)
27 Global Laboratory-Developed Testing Market Outlook, By Academic Institutes (2022-2030) ($MN)
28 Global Laboratory-Developed Testing Market Outlook, By Hospital Laboratories (2022-2030) ($MN)
29 Global Laboratory-Developed Testing Market Outlook, By Clinical Research Organizations (2022-2030) ($MN)
30 Global Laboratory-Developed Testing Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
